---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-000211"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2023-01-12T23:59:59+00:00"
generated_at: "2026-06-20T15:57:59.089439+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Cosmos Health extends LOI to acquire Cana Labs; renegotiates payment terms

## Summary
- Updated binding LOI to acquire Greek pharma company Cana Laboratories; effective until May 31, 2023.
- Acquisition price renegotiated with improved payment terms; no dollar amount disclosed.
- Cana owns a 54,000 sq ft GMP-certified production facility in Athens, Greece.
- Cana has partnerships with AstraZeneca, Merck, Medtronic, Nestle, and others.
- CEO says acquisition would vertically integrate manufacturing and expand product portfolio.

## SEC filing metadata
- accession: 0001477932-23-000211
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2023-01-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793223000211/0001477932-23-000211-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793223000211/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-000211
- JSON: https://secwatch.observer/filing/0001477932-23-000211.json
- Plain text: https://secwatch.observer/filing/0001477932-23-000211.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.